title: Absence of clinical symptoms following the first injection of anti-T cell receptor monoclonal antibody (BMA 031) despite isolated TNF release.
authors.affiliation: INSERM U 25 and Transplantation Unit, Hôpital Necker, Paris, France.
authors.forename: L
authors.initials: L
authors.lastname: Chatenoud
authors.forename: C
authors.initials: C
authors.lastname: Legendre
authors.forename: R
authors.initials: R
authors.lastname: Kurrle
authors.forename: H
authors.initials: H
authors.lastname: Kreis
authors.forename: J F
authors.initials: JF
authors.lastname: Bach
mesh_terms: D000818:Animals; D000911:Antibodies, Monoclonal / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D007165:Immunosuppression Therapy; D016030:Kidney Transplantation; D051379:Mice; D011948:Receptors, Antigen, T-Cell / Q000276:immunology*; D014184:Transplantation, Homologous; D014409:Tumor Necrosis Factor-alpha / Q000378:metabolism*
chemical_list: D000911:Antibodies, Monoclonal; D011948:Receptors, Antigen, T-Cell; D014409:Tumor Necrosis Factor-alpha